One pill.
Two proven
PAH treatments.
Together for
OPSYNVI® is the first and only once-daily treatment that targets two foundational PAH pathways with a single pill.
A first-of-its-kind treatment combining
macitentan and tadalafil in a
once-daily pill.
Learn How OPSYNVI® Can Help You Manage Your PAH
Download the OPSYNVI® brochure for quick access to the benefits and patient support options available to you.
Download Brochure
Support Every Step of the Way
PAH Companion withMe* is a suite of patient support resources customized for your specific needs, questions, and interests. Once you and your doctor have decided that a Janssen PAH medication is right for you, one-on-one educational conversations with a dedicated PAH Companion coupled with access to current PAH tools and resources can help you take a more active role in your care.
PAH Companion withMe is limited to education about your Janssen PAH therapy, its administration, and/or PAH. It is not intended to provide medical advice, replace a treatment plan you receive from your healthcare team, or serve as a reason for you to start or stay on treatment.
*PAH Companion withMe requires a completed authorization form to enroll.
Explore Support Resources
94% of patients who have enrolled and engaged with a dedicated PAH Companion would recommend the program to others.
Stay in the Know With OPSYNVI®
Exciting updates are underway! Sign up for exclusive updates on OPSYNVI®.
Sign Up
